Welcome to LookChem.com Sign In|Join Free
  • or
N-(6-formyl-4-oxo-1H-pteridin-2-yl)acetamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

29769-49-1

Post Buying Request

29769-49-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

29769-49-1 Usage

Chemical Properties

Yellow Solid

Uses

pteridine derivative

Check Digit Verification of cas no

The CAS Registry Mumber 29769-49-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,7,6 and 9 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 29769-49:
(7*2)+(6*9)+(5*7)+(4*6)+(3*9)+(2*4)+(1*9)=171
171 % 10 = 1
So 29769-49-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H7N5O3/c1-4(16)11-9-13-7-6(8(17)14-9)12-5(3-15)2-10-7/h2-3H,1H3,(H2,10,11,13,14,16,17)

29769-49-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(6-formyl-4-oxo-1H-pteridin-2-yl)acetamide

1.2 Other means of identification

Product number -
Other names 2-ACETAMIDO-6-FORMYLPTERIDIN-4-ONE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:29769-49-1 SDS

29769-49-1Synthetic route

6-formylpterin
712-30-1

6-formylpterin

acetic anhydride
108-24-7

acetic anhydride

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

Conditions
ConditionsYield
at 100℃; for 10h;69%
In neat (no solvent) at 100℃; for 15h; Inert atmosphere;60%
Reflux;
2-acetylamino-4-hydroxy-6-formylpteridine dimethyl acetal

2-acetylamino-4-hydroxy-6-formylpteridine dimethyl acetal

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

Conditions
ConditionsYield
With formic acid at 20℃; for 0.5h;67%
With formic acid; water at 25℃; for 2h; Yield given;
(1R,2S,3R)-1-(2-acetylpterin-6-yl)-1,2,3,4-tetrahydroxybutane

(1R,2S,3R)-1-(2-acetylpterin-6-yl)-1,2,3,4-tetrahydroxybutane

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

Conditions
ConditionsYield
With sodium periodate In water for 0.1h; Irradiation;34%
(1R,2R,3R)-1-(2-acetylpterin-6-yl)-1,2,3,4-tetrahydroxybutane

(1R,2R,3R)-1-(2-acetylpterin-6-yl)-1,2,3,4-tetrahydroxybutane

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

Conditions
ConditionsYield
With sodium periodate In water for 0.133333h; Irradiation;32%
N-(6-diethoxymethyl-4-oxo-3,4-dihydro-pteridin-2-yl)-acetamide
92104-52-4

N-(6-diethoxymethyl-4-oxo-3,4-dihydro-pteridin-2-yl)-acetamide

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

Conditions
ConditionsYield
With formic acid
With formic acid
N-(6-methyl-4-oxo-1,4-dihydropteridin-2-yl)acetamide
19962-30-2

N-(6-methyl-4-oxo-1,4-dihydropteridin-2-yl)acetamide

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

Conditions
ConditionsYield
With selenium(IV) oxide In acetic acid at 100℃; for 8.5h; Yield given;
N2'-acetyl-6-diacetoxymethylpterin
92972-04-8

N2'-acetyl-6-diacetoxymethylpterin

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

Conditions
ConditionsYield
With hydrogenchloride Product distribution; Heating;
2,4-diamino-6-formylpteridine dimethyl acetal
64440-78-4

2,4-diamino-6-formylpteridine dimethyl acetal

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 92.1 percent / 5 percent aq. NaOH / 0.17 h / Heating
2: 100 percent / aq. formic acid / 0.5 h / 20 °C
3: 69 percent / 10 h / 100 °C
View Scheme
2-amino-4-hydroxy-6-formylpteridine dimethyl acetal
59453-01-9

2-amino-4-hydroxy-6-formylpteridine dimethyl acetal

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 100 percent / aq. formic acid / 0.5 h / 20 °C
2: 69 percent / 10 h / 100 °C
View Scheme
Multi-step reaction with 2 steps
1: 74 percent / 4 h / 100 °C
2: HCOOH, H2O / 2 h / 25 °C
View Scheme
2-amino-3-cyano-5-formylpyrazine dimethyl acetal
64440-77-3

2-amino-3-cyano-5-formylpyrazine dimethyl acetal

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 86.5 percent / MeONa / methanol / 18 h / 70 °C
2: 92.1 percent / 5 percent aq. NaOH / 0.17 h / Heating
3: 100 percent / aq. formic acid / 0.5 h / 20 °C
4: 69 percent / 10 h / 100 °C
View Scheme
2-amino-6-diethoxymethyl-3H-pteridin-4-one
4227-30-9

2-amino-6-diethoxymethyl-3H-pteridin-4-one

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
2: aqueous formic acid
View Scheme
Multi-step reaction with 2 steps
2: formic acid
View Scheme
ethanol
64-17-5

ethanol

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

C11H11N5O4
1172621-52-1

C11H11N5O4

Conditions
ConditionsYield
With oxygen; Thiamine hydrochloride; triethylamine for 3h; Reflux;79%
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

2-acetamido-6-(hydroxyiminomethyl)lpteridin-4(3H)-one
120483-38-7

2-acetamido-6-(hydroxyiminomethyl)lpteridin-4(3H)-one

Conditions
ConditionsYield
With hydroxylamine hydrochloride In water at 20℃;75%
N-(6-amino-2-chloronicotinoyl)-L-glutamic acid di-tert-butyl ester
1417734-07-6

N-(6-amino-2-chloronicotinoyl)-L-glutamic acid di-tert-butyl ester

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

N2-acetyl-3′-aza-2′-chlorofolic acid di-tert-butylester
1417734-02-1

N2-acetyl-3′-aza-2′-chlorofolic acid di-tert-butylester

Conditions
ConditionsYield
Stage #1: N-(6-amino-2-chloronicotinoyl)-L-glutamic acid di-tert-butyl ester; 2-acetylamino-4-hydroxy-6-formylpteridine With tetraethoxy orthosilicate; acetic acid at 55℃; for 6h;
Stage #2: With sodium triacetoxyborohydride at 20℃; for 1h;
75%
With tetraethoxy orthosilicate; sodium tris(acetoxy)borohydride; acetic acid
N-(6-amino-2-fluoronicotinoyl)-L-glutamic acid di-tert-butyl ester
1417734-08-7

N-(6-amino-2-fluoronicotinoyl)-L-glutamic acid di-tert-butyl ester

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

N2-acetyl-3′-aza-2′-fluorofolic acid di-tert-butylester
1417734-03-2

N2-acetyl-3′-aza-2′-fluorofolic acid di-tert-butylester

Conditions
ConditionsYield
Stage #1: N-(6-amino-2-fluoronicotinoyl)-L-glutamic acid di-tert-butyl ester; 2-acetylamino-4-hydroxy-6-formylpteridine With acetic acid at 20℃; for 7h; Molecular sieve;
Stage #2: With sodium triacetoxyborohydride at 20℃; for 19.5h;
71%
With sodium tris(acetoxy)borohydride; acetic acid Molecular sieve;
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

[2H4]p-aminobenzoylglutamic acid
461426-34-6

[2H4]p-aminobenzoylglutamic acid

N2-acetyl[2H4]folic acid
461426-36-8

N2-acetyl[2H4]folic acid

Conditions
ConditionsYield
With dimethylamine borane; acetic acid at 60℃; for 0.333333h;35%
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

N(2)-acetylfolic acid
2544-29-8

N(2)-acetylfolic acid

Conditions
ConditionsYield
With para-thiocresol
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

N-(4-aminobenzoyl)-L-glutamic acid
4271-30-1

N-(4-aminobenzoyl)-L-glutamic acid

N-{4-[(2-acetylamino-4-oxo-3,4-dihydro-pteridin-6-ylmethylen)-amino]-benzoyl}-L-glutamic acid
119187-38-1

N-{4-[(2-acetylamino-4-oxo-3,4-dihydro-pteridin-6-ylmethylen)-amino]-benzoyl}-L-glutamic acid

Conditions
ConditionsYield
With ethanol
N-(2-amino-thiazole-4-carbonyl)-glutamic acid diethyl ester
40283-42-9

N-(2-amino-thiazole-4-carbonyl)-glutamic acid diethyl ester

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

N-{2-[(2-amino-4-oxo-3,4-dihydro-pteridin-6-ylmethyl)-amino]-thiazole-4-carbonyl}-glutamic acid
37746-93-3

N-{2-[(2-amino-4-oxo-3,4-dihydro-pteridin-6-ylmethyl)-amino]-thiazole-4-carbonyl}-glutamic acid

Conditions
ConditionsYield
(i) 4-methyl-thiophenol, MeOCH2CH2OH, (ii) aq. NaOH, Et2O; Multistep reaction;
N-(2-amino-thiazole-5-carbonyl)-glutamic acid diethyl ester
40283-47-4

N-(2-amino-thiazole-5-carbonyl)-glutamic acid diethyl ester

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

N-{2-[(2-amino-4-oxo-3,4-dihydro-pteridin-6-ylmethyl)-amino]-thiazole-5-carbonyl}-glutamic acid
37746-94-4

N-{2-[(2-amino-4-oxo-3,4-dihydro-pteridin-6-ylmethyl)-amino]-thiazole-5-carbonyl}-glutamic acid

Conditions
ConditionsYield
(i) 4-methyl-thiophenol, MeOCH2CH2OH, (ii) aq. NaOH, Et2O; Multistep reaction;
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

6-formylpterin
712-30-1

6-formylpterin

Conditions
ConditionsYield
With hydrogenchloride Product distribution; Heating;
formic acid
64-18-6

formic acid

2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

N-<4-amino-benzene>-L-glutamic acid

N-<4-amino-benzene>-L-glutamic acid

N-(N2-acetyl-10-formyl-pteroyl)-L-glutamic acid
3946-50-7

N-(N2-acetyl-10-formyl-pteroyl)-L-glutamic acid

Conditions
ConditionsYield
With acetic anhydride
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

<2',3',5',6'-2H4>folic acid
171777-72-3

<2',3',5',6'-2H4>folic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 35 percent / glacial acetic acid; dimethylaminoborane / 0.33 h / 60 °C
2: 80 percent / aq. NaOH / 6 h / 20 °C
View Scheme
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

[2H4]10-formylfolic acid

[2H4]10-formylfolic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 35 percent / glacial acetic acid; dimethylaminoborane / 0.33 h / 60 °C
2: 80 percent / aq. NaOH / 6 h / 20 °C
3: 16 percent / 3 h / 60 °C
View Scheme
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

6-cyanopterin
120483-42-3

6-cyanopterin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 75 percent / hydroxylamine hydrochloride / H2O / 20 °C
2: 80 percent / acetic acid / 0.17 h / Heating
3: acetic anhydride / acetic acid / 15 h / Heating
4: 75 percent / ethanol; H2O / 6 h / 80 °C
View Scheme
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

6-aminomethyl-7,8-dihydro-6H-pterin
120483-45-6

6-aminomethyl-7,8-dihydro-6H-pterin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 75 percent / hydroxylamine hydrochloride / H2O / 20 °C
2: 80 percent / acetic acid / 0.17 h / Heating
3: acetic anhydride / acetic acid / 15 h / Heating
4: H2 / prereduced platinum oxide / trifluoroacetic acid / 12 h
5: 3 M HCl / 48 h / Ambient temperature
6: Br2
View Scheme
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

6-aminomethyl-5,6,7,8-tetrahydropterin
99778-32-2

6-aminomethyl-5,6,7,8-tetrahydropterin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 75 percent / hydroxylamine hydrochloride / H2O / 20 °C
2: 80 percent / acetic acid / 0.17 h / Heating
3: acetic anhydride / acetic acid / 15 h / Heating
4: H2 / prereduced platinum oxide / trifluoroacetic acid / 12 h
5: 3 M HCl / 48 h / Ambient temperature
View Scheme
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

2-acetamido-6-cyanopteridin-4(3H)-one
120483-40-1

2-acetamido-6-cyanopteridin-4(3H)-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 75 percent / hydroxylamine hydrochloride / H2O / 20 °C
2: 80 percent / acetic acid / 0.17 h / Heating
3: acetic anhydride / acetic acid / 15 h / Heating
View Scheme
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

2-acetamido-6-aminomethyl-5,6,7,8-tetrahydropteridin-4(3H)-one
741640-49-3

2-acetamido-6-aminomethyl-5,6,7,8-tetrahydropteridin-4(3H)-one

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 75 percent / hydroxylamine hydrochloride / H2O / 20 °C
2: 80 percent / acetic acid / 0.17 h / Heating
3: acetic anhydride / acetic acid / 15 h / Heating
4: H2 / prereduced platinum oxide / trifluoroacetic acid / 12 h
View Scheme
2-acetylamino-4-hydroxy-6-formylpteridine
29769-49-1

2-acetylamino-4-hydroxy-6-formylpteridine

2-acetamido-6-(acetoxyiminomethyl)pteridin-4(3H)-one
120483-39-8

2-acetamido-6-(acetoxyiminomethyl)pteridin-4(3H)-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 75 percent / hydroxylamine hydrochloride / H2O / 20 °C
2: 80 percent / acetic acid / 0.17 h / Heating
View Scheme

29769-49-1Relevant academic research and scientific papers

Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents

Hajian, Behnoush,Scocchera, Eric,Shoen, Carolyn,Krucinska, Jolanta,Viswanathan, Kishore,G-Dayanandan, Narendran,Erlandsen, Heidi,Estrada, Alexavier,Miku?ová, Katarína,Korduláková, Jana,Cynamon, Michael,Wright, Dennis

, p. 781 - 6,791 (2019/06/18)

The folate biosynthetic pathway offers many druggable targets that have yet to be exploited in tuberculosis therapy. Herein, we have identified a series of small molecules that interrupt Mycobacterium tuberculosis (Mtb) folate metabolism by dual targeting of dihydrofolate reductase (DHFR), a key enzyme in the folate pathway, and its functional analog, Rv2671. We have also compared the antifolate activity of these compounds with that of para-aminosalicylic acid (PAS). We found that the bioactive metabolite of PAS, in addition to previously reported activity against DHFR, inhibits flavin-dependent thymidylate synthase in Mtb, suggesting a multi-targeted mechanism of action for this drug. Finally, we have shown that antifolate treatment in Mtb decreases the production of mycolic acids, most likely due to perturbation of the activated methyl cycle. We conclude that multi-targeting of the folate pathway in Mtb is associated with highly potent anti-mycobacterial activity. Hajian et al. have investigated the inhibitory activity of a series of small-molecule antifolates and para-aminosalicylic acid against Mycobacterium tuberculosis, the causative agent of tuberculosis, and show that these compounds exert their activity by acting on multiple targets within the folate biosynthetic pathway.

Synthesis and analysis of bacterial folate metabolism intermediates and antifolates

Dawadi, Surendra,Kordus, Shannon L.,Baughn, Anthony D.,Aldrich, Courtney C.

, p. 5220 - 5223 (2017/11/06)

The mechanism of action of para-aminosalicylic acid (PAS), a drug used to treat drug-resistant tuberculosis (TB), has been confirmed through the first synthesis and biochemical characterization of its active metabolite 7. The synthesis features the coupling of N2-acetyl-6-formylpterin obtained from the degradation of folic acid and appropriately functionalized arylamines to form Schiff bases. The sequential chemoselective reduction of the imine and pterin ring led to the formation of dihydrofolate analogue 7 and two other dihydropteroate species.

Pterin–sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents

Zhao, Ying,Shadrick, William R.,Wallace, Miranda J.,Wu, Yinan,Griffith, Elizabeth C.,Qi, Jianjun,Yun, Mi-Kyung,White, Stephen W.,Lee, Richard E.

, p. 3950 - 3954 (2016/08/01)

The sulfonamide class of antibiotics has been in continuous use for over 70?years. They are thought to act by directly inhibiting dihydropteroate synthase (DHPS), and also acting as prodrugs that sequester pterin pools by forming dead end pterin–sulfonamide conjugates. In this study, eight pterin–sulfonamide conjugates were synthesized using a novel synthetic strategy and their biochemical and microbiological properties were investigated. The conjugates were shown to competitively inhibit DHPS, and inhibition was enhanced by the presence of pyrophosphate that is crucial to catalysis and is known to promote an ordering of the DHPS active site. The co-crystal structure of Yersinia pestis DHPS bound to one of the more potent conjugates revealed a mode of binding that is similar to that of the enzymatic product analog pteroic acid. The antimicrobial activities of the pterin–sulfonamide conjugates were measured against Escherichia coli in the presence and absence of folate precursors and dependent metabolites. These results show that the conjugates have appreciable antibacterial activity and act by an on target, anti-folate pathway mechanism rather than as simple dead end products.

Oxidative removal of heterocyclic alkyl or sugar side chain by microwave: A simple step to xanthopterin, 6-formylpterin, and 3-hydroxymethyl-2(1H)- quinoxalinone

Goswami, Shyamaprosad,Maity, Annada C.

, p. 1118 - 1119 (2008/02/10)

One-step microwave-assisted oxidative removal of 3-methyl and 3-sugar side chain in 2(lH)-quinoxalinone system by selenium dioxide and sodium periodate respectively resulting 2(1H)quinoxalinone has been reported. Similarly xanthopterin (as acetyl derivative 11) was isolated from selenium dioxide oxidation of 7-methylxanthopterin. In the absence of adjacent lactam moiety, sodium periodate efficiently oxidizes 2-acetylaminopterin tetrols 7 and 8 to 2-acetylamino-6-formylpterin (16) and the quinoxaline tetrols 9 and 10 respectively to quinoxaline aldehyde 17. However, all the compounds remained unchanged on refluxing with selenium dioxide. The new quinoxalone compounds 15 and 18 were simply synthesized by manganese dioxide oxidation of the completely unprotected 3-substituted sugar of 2(lH)-quinoxalinone 5 and quinoxaline 10 respectively under microwave condition. Copyright

Syntheses of labeled vitamers of folic acid to be used as internal standards in stable isotope dilution assays

Freisleben, Achim,Schieberle, Peter,Rychlik, Michael

, p. 4760 - 4768 (2007/10/03)

[2H4]Folic acid was synthesized by deuterating p-aminobenzoic acid, which was then coupled to glutamic acid and 6-formylpterin, Using [2H4]folic acid as starting component enabled the preparation of labeled vitamers tetrahydrofolate, 5-formyltetrahydrofolate, 5-methyltetrahydrofolate, and 10-formylfolate which were characterized by electrospray mass spectrometry and collision-induced dissociation. The mass spectrometric studies confirmed that the compounds could be used as internal standards in stable isotope dilution assays.

The synthesis of folic acid, multiply labelled with stable isotopes, for bio-availability studies in human nutrition

Maunder, Peter,Finglas, Paul M.,Mallet, Anthony I.,Mellon, Fred A.,Aaqib Razzaque,Ridge, Brian,Vahteristo, Liisa,Witthoeft, Cornelia

, p. 1311 - 1323 (2007/10/03)

Two different methods for the synthesis of folic acid, which are suitable for the incorporation of compounds multiply labelled with stable isotopes, are described. The first method is based on the use of a novel reductive amination to link 2-acetyIamino-4-hydroxy-6-formylpteridine withp-aminobenzoyl-L-glutamic acid. The second method is based on the penultimate formation of an amide bond between Ar-2-acetyl-Ar-10-trifluoroacetyIpteroic acid and dimethyl L-glutamate. Both methods have been used to transform [13C6]aniline into folic acid, labelled with [13C6] in the p-aminobenzoate moiety, and [3,3,4,4-2H4]-L-glutamic acid into folic acid, labelled with [2H4] in the glutamate moiety. Doubly labelled [13C6,2H 4]-p-aminobenzoyl-L-glutamate has also been prepared by the former method.

Preparation of [2',3',5',6'-2H4]pteroylglutamic acid

Dueker,Jones,Smith,Clifford

, p. 981 - 991 (2007/10/02)

Folic acid plays a key role in nucleic acid biosynthesis, essential for normal cell proliferation and function. Localized folate deficiencies may be related to changes in cytology associated with cancer development; analogs of folic acid, such as methotrexate, are potent chemotherapeutic agents and are widely used either alone or in combination therapy for many types of cancer. In this report we describe the synthesis of a tetra-deuterated folic acid from perdeuterated toluene. The primary intermediate, N-(4-amino [2,3,5,6-2H4]benzoyl)-L-glutamic acid diethyl ester was coupled to N(2')-acetyl-6-formylpterin to create [2',3',5',6'-2H4]folic acid. A similar scheme can be used for the preparation of F [1',2',3',4',5',6'-13C6]folic acid from [13C6] ring labeled toluene.

The Synthesis of 6-Aminomethyl-5,6,7,8-tetrahydropterin

Waring, Paul

, p. 667 - 676 (2007/10/02)

6-Aminomethyl-5,6,7,8-tetrahydropterin has been prepared by reduction of 2-acetamido-6-cyanopteridin-4(3H)-one to 2-acetamido-6-aminomethyl-5,6,7,8-tetrahydropteridin-4(3H)-one followed by acid hydrolysis.The hitherto undescribed 6-cyanopterin was prepared by careful hydrolysis of the 2-acetamido compound prepared by dehydration of the oxime derived from 2-acetamido-6-formylpteridin-4(3H)-one.The latter was prepared by selenium dioxide oxidation of the methyl compound.Oxidation of 6-aminomethyl-5,6,7,8-tetrahydropterin at neutral pH appears to proceed with significant side-chain loss in Tris buffer but not in phosphate buffer.

N2'-Acetyl-6-diacetoxymethylpterin

Boyle, Peter H.,O'Mahony, Mary J.

, p. 909 (2007/10/02)

Treatment of folic acid with bromine in 48 percent hydrobromic acid gives the hydrobromide salt of 6-formylpterin (1), and acetylation of 1 with recovered acetic anhydride leads to N2'-acetyl-6-diacetoxymethylpterin (3).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 29769-49-1